These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20449511)

  • 1. A panel of subunit-selective activity-based proteasome probes.
    Verdoes M; Willems LI; van der Linden WA; Duivenvoorden BA; van der Marel GA; Florea BI; Kisselev AF; Overkleeft HS
    Org Biomol Chem; 2010 Jun; 8(12):2719-27. PubMed ID: 20449511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors.
    Besse A; Besse L; Kraus M; Mendez-Lopez M; Bader J; Xin BT; de Bruin G; Maurits E; Overkleeft HS; Driessen C
    Cell Chem Biol; 2019 Mar; 26(3):340-351.e3. PubMed ID: 30612952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit beta5t.
    Florea BI; Verdoes M; Li N; van der Linden WA; Geurink PP; van den Elst H; Hofmann T; de Ru A; van Veelen PA; Tanaka K; Sasaki K; Murata S; den Dulk H; Brouwer J; Ossendorp FA; Kisselev AF; Overkleeft HS
    Chem Biol; 2010 Aug; 17(8):795-801. PubMed ID: 20797608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of proteasome subunit selectivity of syringolins.
    Tatsumi K; Kitahata S; Komatani Y; Katsuyama A; Yakushiji F; Ichikawa S
    Bioorg Med Chem; 2024 May; 106():117733. PubMed ID: 38704960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational inhibition studies of the human proteasome by argyrin-based analogues with subunit specificity.
    Loizidou EZ; Zeinalipour-Yazdi CD
    Chem Biol Drug Des; 2014 Jul; 84(1):99-107. PubMed ID: 24521156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenoxypropanolamine derivatives as selective inhibitors of the 20S proteasome β1 and β5 subunits.
    Hovhannisyan AA; Pham TH; Bouvier D; Tan X; Touhar S; Mkryan GG; Dallakyan AM; El Amri C; Melikyan GS; Reboud-Ravaux M; Bouvier-Durand M
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5172-5178. PubMed ID: 29113763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i).
    Klein M; Busch M; Friese-Hamim M; Crosignani S; Fuchss T; Musil D; Rohdich F; Sanderson MP; Seenisamy J; Walter-Bausch G; Zanelli U; Hewitt P; Esdar C; Schadt O
    J Med Chem; 2021 Jul; 64(14):10230-10245. PubMed ID: 34228444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.
    Sosič I; Gobec M; Brus B; Knez D; Živec M; Konc J; Lešnik S; Ogrizek M; Obreza A; Žigon D; Janežič D; Mlinarič-Raščan I; Gobec S
    Angew Chem Int Ed Engl; 2016 May; 55(19):5745-8. PubMed ID: 27037901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Analyses of Substrate Preferences of 20S Proteasomes Using Peptidic Epoxyketone Inhibitors.
    Huber EM; de Bruin G; Heinemeyer W; Paniagua Soriano G; Overkleeft HS; Groll M
    J Am Chem Soc; 2015 Jun; 137(24):7835-42. PubMed ID: 26020686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome activity imaging and profiling characterizes bacterial effector syringolin A.
    Kolodziejek I; Misas-Villamil JC; Kaschani F; Clerc J; Gu C; Krahn D; Niessen S; Verdoes M; Willems LI; Overkleeft HS; Kaiser M; van der Hoorn RA
    Plant Physiol; 2011 Jan; 155(1):477-89. PubMed ID: 21045122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Substrates and Activity-Based Probes for Imaging of the Human Constitutive 20S Proteasome in Cells and Blood Samples.
    Rut W; Poręba M; Kasperkiewicz P; Snipas SJ; Drąg M
    J Med Chem; 2018 Jun; 61(12):5222-5234. PubMed ID: 29806773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits.
    Maurits E; Degeling CG; Kisselev AF; Florea BI; Overkleeft HS
    Chembiochem; 2020 Nov; 21(22):3220-3224. PubMed ID: 32598532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent Probes with Unnatural Amino Acids to Monitor Proteasome Activity in Real-Time.
    Zerfas BL; Coleman RA; Salazar-Chaparro AF; Macatangay NJ; Trader DJ
    ACS Chem Biol; 2020 Sep; 15(9):2588-2596. PubMed ID: 32786259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.
    Villoutreix BO; Khatib AM; Cheng Y; Miteva MA; Maréchal X; Vidal J; Reboud-Ravaux M
    Oncotarget; 2017 Feb; 8(6):10437-10449. PubMed ID: 28060729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling proteasome activity in tissue with fluorescent probes.
    Berkers CR; van Leeuwen FW; Groothuis TA; Peperzak V; van Tilburg EW; Borst J; Neefjes JJ; Ovaa H
    Mol Pharm; 2007; 4(5):739-48. PubMed ID: 17708652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome Subunit Selective Activity-Based Probes Report on Proteasome Core Particle Composition in a Native Polyacrylamide Gel Electrophoresis Fluorescence-Resonance Energy Transfer Assay.
    de Bruin G; Xin BT; Florea BI; Overkleeft HS
    J Am Chem Soc; 2016 Aug; 138(31):9874-80. PubMed ID: 27428761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tunable Probes with Direct Fluorescence Signals for the Constitutive and Immunoproteasome.
    Dubiella C; Cui H; Groll M
    Angew Chem Int Ed Engl; 2016 Oct; 55(42):13330-13334. PubMed ID: 27709817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Novel Amides as Noncovalent Inhibitors of Immunoproteasomes.
    Ettari R; Cerchia C; Maiorana S; Guccione M; Novellino E; Bitto A; Grasso S; Lavecchia A; Zappalà M
    ChemMedChem; 2019 Apr; 14(8):842-852. PubMed ID: 30829448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptido sulfonyl fluorides as new powerful proteasome inhibitors.
    Brouwer AJ; Jonker A; Werkhoven P; Kuo E; Li N; Gallastegui N; Kemmink J; Florea BI; Groll M; Overkleeft HS; Liskamp RM
    J Med Chem; 2012 Dec; 55(24):10995-1003. PubMed ID: 23170994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition on Proteasome β1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells.
    Li D; Lu Y; Sun P; Feng LX; Liu M; Hu LH; Wu WY; Jiang BH; Yang M; Qu XB; Guo DA; Liu X
    PLoS One; 2015; 10(10):e0141681. PubMed ID: 26512898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.